Phase 2 Study of VGT-309 in Lung Cancer

Similar pages

• Trial
  Phase 2B Safety and Efficacy Study of VGT-309 in Subjects With Cancer in the Lung.

  Shares Abenacianine, Vergent Bioscience, Lung cancer (all types) and the tag pipeline.

• Trial
  Fluorescent Probe VGT-309 to ID Cancerous Colorectal Lesions During Augmented Colonoscopy

  Shares Abenacianine, Vergent Bioscience and the tag pipeline.

• Trial
  Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

  Shares Abenacianine, Vergent Bioscience and the tag pipeline.

• Trial
  ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting

  Shares Lung cancer (all types) and the tag pipeline.

• Trial
  Mithramycin for Lung, Esophagus, and Other Chest Cancers

  Shares Lung cancer (all types) and the tag pipeline.

• Treatment
  ML-016

  Shares Lung cancer (all types) and the tag pipeline.

• Trial
  Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

  Shares Lung cancer (all types) and the tag pipeline.

• Trial
  AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

  Shares Lung cancer (all types) and the tag pipeline.